The effects of abaloparatide on hip geometry and biomechanical properties in Japanese osteoporotic patients assessed using DXA-based hip structural analysis: results of the Japanese phase 3 ACTIVE-J trial

SUMMARY: Daily subcutaneous injection of 80 μg abaloparatide increased bone mineral density in Japanese patients with osteoporosis at high fracture risk in the ACTIVE-J trial. Dual-energy X-ray absorptiometry–based hip structural analysis from ACTIVE-J data showed improved hip geometry and biomechan...

Descripción completa

Detalles Bibliográficos
Autores principales: Sone, Teruki, Ohnaru, Kazuhiro, Sugai, Takumi, Yamashita, Akiko, Okimoto, Nobukazu, Inoue, Tetsuo, Matsumoto, Toshio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer London 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10687120/
https://www.ncbi.nlm.nih.gov/pubmed/38030806
http://dx.doi.org/10.1007/s11657-023-01344-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10687120/
https://www.ncbi.nlm.nih.gov/pubmed/38030806
http://dx.doi.org/10.1007/s11657-023-01344-5

Ejemplares similares